MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$7,349,056
EPS
-$0.13
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development expenses
3,457,032 5,841,871.5* 4,576,389 4,212,918
General and administrative expenses
3,064,055 2,056,848* 3,563,753 3,410,433
Total operating expenses
6,521,087 7,898,719.5 8,140,142 7,623,351
Loss from operations
-6,521,087 -7,898,719.5* -8,140,142 -7,623,351
Interest income
186,814 295,141.5* 281,109 333,624
Interest expense
1,014,783 396,318.5* 1,150,378 2,144,481
Interest income (expenses), net
-827,969 -101,177* -869,269 -1,810,857
Loss before income taxes
-7,349,056 -7,999,896.5* -9,009,411 -9,434,208
Benefit for income taxes
0 -1,169,820* 0 0
Net loss
-7,349,056 -6,830,076.5 -9,009,411 -9,434,208
Basic EPS
-0.13 -0.147 -0.19 -0.21
Diluted EPS
-0.13 -0.147 -0.19 -0.21
Basic Average Shares
55,496,279 46,380,807 46,869,531 45,902,502
Diluted Average Shares
55,496,279 46,380,807 46,869,531 45,902,502
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$7,349,056 Loss before incometaxes-$7,349,056 Loss from operations-$6,521,087 Interest income(expenses), net-$827,969 Interest income$186,814 Total operatingexpenses$6,521,087 Interest expense$1,014,783 Research and developmentexpenses$3,457,032 General andadministrative expenses$3,064,055

PDS Biotechnology Corp (PDSB)

PDS Biotechnology Corp (PDSB)